Navigation Links
Genomatix to partner in $41 million European epigenomics consortium
Date:10/17/2011

Munich, Germany, 17 October 2011 - Genomatix is among the 41 partners of the BLUEPRINT epigenome consortium funded by the European Commission as a high impact project within its seventh framework program (FP7). Genomatix' contributions will be next generation sequencing data analysis and the development of an intuitive GUI to make the project's results easily accessible to researchers within and outside the consortium.

"To be part of, and to get substantial funding from this ambitious project, is a pleasant affirmation of our research and development efforts to provide high quality data analysis in a very usable way for biologists", says Dr. Martin Seifert, CEO of Genomatix. "We highly appreciate the European Commission's commitment to support SMEs in its current FP7 program, as it enables us to participate in a high-profile research project that will generate fascinating new insights into epigenomics. It is of direct relevance to our business, as it will help us to offer our customers an even broader biological data background for their research. This will improve the understanding of molecular processes and hence lead to better biomedical applications."

Dr. Korbinian Grote, product manager at Genomatix adds: "The BLUEPRINT epigenome project is a chance to work with high-quality epigenomics data from renowned institutions and labs from all over Europe. It will help us to further improve our existing line of next generation sequencing analysis products and will lead to the implementation of new ideas tailored towards the integration of epigenomic data into our interfaces and visualizations."


'/>"/>

Contact: Korbinian Grote
grote@genomatix.de
Genomatix Software GmbH
Source:Eurekalert

Page: 1

Related biology news :

1. Genomatix joins Illumina-Connect program
2. Boehringer Ingelheim uses Genomatix Next Generation Sequencing data analysis systems
3. CRG buys Genomatix Next Generation Sequencing analysis solution
4. Genomatix gets patent for comparative genomics method
5. MCTP bought Genomatix NextGen Sequencing analysis stations
6. University of Michigan installs second Genomatix Genome Analyzer
7. Genomatix gives a hand in the analysis of Wayne States sequencing projects
8. Eurofins MWG Operon and Genomatix launch strategic alliance
9. Eurofins MWG Operon and Genomatix developed most complete human exome array
10. Genomatix, USU and HJF execute a CRADA: Prostate cancer prognostic marker discovery by NGS
11. Genomatix wins "Most Creative Visualization" award at iDEA Challenge 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2015)... BOSTON and TELTOW, Germany ... SensoMotoric Instruments (SMI), a world leader in Eye ... the completion of its OEM Eye Tracking Platform for ... Eye Tracking Platform contains reference designs for seamless integration ... kiosk systems, virtual reality HMDs and augmented reality smart ...
(Date:8/6/2015)... REDWOOD CITY, Calif. , Aug. 6, 2015 ... (D-Silicon Valley) will visit Crossmatch ™ to ... secure networks and protect data. Crossmatch is a ... solutions whose technologies and expertise are helping federal ... operational efficiency and security.   "The ...
(Date:8/6/2015)... , Aug. 6, 2015 Synaptics ... of human interface solutions, today announced collaboration with ... on Windows 10. Microsoft leveraged Synaptics, deep expertise ... operating system. Through stringent testing, ... fully certified with Microsoft,s Precision TouchPad (PTP) specification ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Rep. Honda to Visit Crossmatch in Redwood City 2Synaptics Chosen for Human Interface Co-Development on Windows 10 2
... from the University of Santiago de Compostela (USC) have ... The results show that the principal goal of young ... The most antisocial among them place greater importance on ... most importance on are to do with leaving home, ...
... Research currently being undertaken at the University of ... Abdominal Aortic Aneurysms (AAA) in men. In her ... into the causes of the male predominance of AAA, ... disease. Preliminary results from the study will be showcased ...
... KNOXVILLE -- By examining 800,000-year-old polar ice, scientists increasingly are ... melt and that carbon dioxide has become more abundant in ... Jrme Chappellaz has been examining ice cores collected from deep ... studies on the interconnecting air spaces of old snow -- ...
Cached Biology News:Teenagers want to finish their studies and leave home 2Increased likelihood of male death from disease 2Scientist links increase in greenhouse gases to changes in ocean currents 2
(Date:8/31/2015)... ... August 31, 2015 , ... Proove Biosciences, Inc. is a finalist for the ... Tech Awards. , Now in its 22nd year, this premier awards event celebrates the ... the nation and around the world. The OC Tech Alliance will announce all winners ...
(Date:8/28/2015)... According to a new market ... Systems, Thawing Equipment, Alarms), by Biospecimen (Human Tissue, Stem ... User - Global Forecast to 2020", published by MarketsandMarkets, ... 3,731.03 Million by 2020 from USD 2,150.48 Million in ... and 2020. Browse 74 Tables and ...
(Date:8/28/2015)... , Aug. 28, 2015 /PRNewswire/ - RepliCel Life ... regenerative medicine company focused on the development of ... the quarter ended June 30, 2015, corporate highlights, ... management report are available at www.sedar.com ,  ... "RepliCel expects to launch its ...
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... ... opportunity for venture capital funds, investment firms and animal health companies to hear ... have raised $160 million. Several have also received licensing agreements or distribution contracts. ...
Breaking Biology Technology:Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 2Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 3Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 4Biopreservation Market Worth 3,731.03 Million USD by 2020 2Biopreservation Market Worth 3,731.03 Million USD by 2020 3Biopreservation Market Worth 3,731.03 Million USD by 2020 4Biopreservation Market Worth 3,731.03 Million USD by 2020 5RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3
... by Strong Revenue Growth, Conference Call and Webcast to Be Held Today at 5:00 p.m. ET (22:00 CET), ... Q1 2008 (millions) Q1 2007 Comparison ... 164.5% increase Naglazyme Net Product Revenue ... Aldurazyme (net sales by Genzyme) $36.8 ...
... ... - Product revenues increased 30% to a record $59.7 million ... 28,600 new pulse oximeters ... April 29, 2008 Masimo,Corporation (Nasdaq: MASI ), the inventor of Pulse CO-Oximetry and,Measure-Through-Motion-and-Low-Perfusion ...
... transmit medical images via cellular phones that has ... researcher has the potential to provide sophisticated radiological diagnoses ... lacking access to such technology. This would include millions ... areas of developed countries who live considerable distances from ...
Cached Biology Technology:BioMarin Announces First Quarter 2008 Financial Results 2BioMarin Announces First Quarter 2008 Financial Results 3BioMarin Announces First Quarter 2008 Financial Results 4BioMarin Announces First Quarter 2008 Financial Results 5BioMarin Announces First Quarter 2008 Financial Results 6BioMarin Announces First Quarter 2008 Financial Results 7BioMarin Announces First Quarter 2008 Financial Results 8BioMarin Announces First Quarter 2008 Financial Results 9BioMarin Announces First Quarter 2008 Financial Results 10BioMarin Announces First Quarter 2008 Financial Results 11Masimo Reports First Quarter 2008 Financial Results 2Masimo Reports First Quarter 2008 Financial Results 3Masimo Reports First Quarter 2008 Financial Results 4Masimo Reports First Quarter 2008 Financial Results 5Masimo Reports First Quarter 2008 Financial Results 6Masimo Reports First Quarter 2008 Financial Results 7Masimo Reports First Quarter 2008 Financial Results 8Masimo Reports First Quarter 2008 Financial Results 9Masimo Reports First Quarter 2008 Financial Results 10Researchers develop method for transmitting medical images via cell phones 2Researchers develop method for transmitting medical images via cell phones 3Researchers develop method for transmitting medical images via cell phones 4
sterile filtered, off the clot, all male donors, Total Protein: 4.5 to 8.5 g/dl...
Recombinant Mouse MMP-9, CF...
Human/Mouse/Rat JNK Pan Specific Affinity Purified PAb...
Blue Standard is 3-cyano-7-hydroxycoumarin....
Biology Products: